Cardiac arrest & resuscitation

Hyperoxia for accidental hypothermia and increased mortality: a post-hoc analysis of a multicenter prospective observational study

Crit CarePublished Secondary analysis of the ICE-CRASH multicentre prospective observational study

Primary result · 28-day mortalityResult — go to the resultOdds ratio 2.65 95% CI 1.47–4.78

Authors' conclusion

Hyperoxia with PaO2 levels of 300 mmHg or higher before initiating rewarming was associated with increased 28-day mortality in patients with accidental hypothermia.

Study context

Population
Adults with accidental hypothermia (core temperature < 32 °C) without cardiac arrest, PaO2 measured in the ED, admitted 2019–2022eligible
Participants
338 adults
Comparison
Hyperoxia vs no hyperoxia before rewarming
  • Hyperoxian = 65
Primary endpoint
28-day mortality
Follow-up
28 days
Methodological detailspost-hoc analysis, nationwide multicentre, inverse probability weighting with propensity scores
  • Post-hoc analysis
  • Nationwide multicentre
  • Inverse probability weighting with propensity scores

Primary result

As reported in the abstract

Odds ratio

2.65

95% CI 1.47–4.78

P < 0.001

Events by treatment group

Hyperoxia vs Without hyperoxia
OR 2.65 (95% CI 1.47–4.78); P < 0.001
Inverse probability weighting (IPW) analyses with propensity scores: similar results, adjusted OR
1.65 (1.14-2.38); p = 0.008 (95% CI)

Further findings

28-day mortality by subgroup (age, cardiopulmonary disease, hemodynamic instability, hypothermia severity)

Hyperoxia harmful in the elderly, those with cardiopulmonary diseases and severe hypothermia below 28 °C
No effect on mortality in patients with hemodynamic instability on hospital arrival

Original publication

Hyperoxia for accidental hypothermia and increased mortality: a post-hoc analysis of a multicenter prospective observational study. Crit Care. Published 1 April 2023. doi:10.1186/s13054-023-04407-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.